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For more than a quarter of a century antibiotics 
have unceasingly attracted the attention of numerous 
researchers in different branches of science. For those 
working in the fields of medicine and agriculture these 
substances are of importance primarily from a practi- 
cal standpoint as compounds of remarkable biologi- 
cal activity. To chemists their interest lies in their un- 
usual structures and reactions. Biochemists and mole- 
cular biologists regard them first of all as tools for 
studying specific biological processes and structures in 
the cell. It is, therefore, feasible to organize meetings 
of the widely differing specialists in the field of anti- 
biotics to review achievements and discuss the areas 
and problems urgently in need of elucidation. 
Opening the PreSymposium, its Chairman, A.S. 
Khokhlov briefly outlined its objectives and the manner 
of its procedure. His introductory remarks were fol- 
lowed by the reading and discussion of sixteen invited 
papers, which will be briefly reviewed here. 
The papers can be divided into two groups. Most 
of them (those by Sheehan, Sensi, Shemyakin, Boothe, 
Kolosov, Borowski, Thrum, Khokhlov, Yonehara, Bog- 
nar and Gross) were devoted to critically reviewing the 
present state and future trends of the chemistry and 
molecular biology of large groups of antibiotics im- 
portant from either an applied or theoretical point of 
view. The other lectures (Strominger, Weisblum, W. 
Kersten, Hahn and H.Kersten) were devoted to general 
problems directly connected with the mode of action 
of different antibiotics. 
JSheehan (Cambridge, USA) discussed in detail 
studies on the synthesis and chemical transformations 
of the penicillins and cephalosporins which led to sub- 
stances that in one way or another were superior to 
the naturally occurring antibiotics. He briefly discussed 
data on the most important semisynthetic penicillins. 
The author devoted his main attention, however, to 
the total synthesis of cephalosporins and their prepa- 
ration by expansion of the thiazolidine ring of the 
penicillins to the corresponding 6-membered ring of 
the cephalosporins. Such a method involves the con- 
version of phenoxymethylpenicillin into phenoxy- 
methylcephalosporin (scheme 1). 
In the discussion of this lecture A.S.Khokhlov 
(Moscow, USSR) spoke about modification of peni- 
cillins at positions other than those mentioned by 
Sheehan. In particular, he pointed to the synthesis 
of homo- and bishomopenicillins, compounds posses- 
sing antipenicillinase activity, S.A.Giller (Riga, USSR) 
discussed the preparation of semisynthetic penicillins 
containing nitrofuran residues. The latter also impart 
antifungal activity to the penicillins. 
Similar in spirit in its synthetic part to Sheehan’s 
paper was the report by Sensi (Milan, Italy) on the 
rifamycins in which he described the long search for 
methods of modifying the naturally occurring rifamy- 
tin B so as to obtain derivatives with properties excel- 
ling those of the parent compound. Study of the bio- 
logical properties of numerous such products showed 
that the enhanced in vitro activity (e.g. in case of 
quinoneimine analogs) does not necessarily correlate 
with in vivo data. Also (for instance on modification 
of the rifamycin B chromophore to give pitenazine, 
phenoxazine or indole compounds) when compounds 
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highly active in viva were obtained, they were often 
poorly absorbed or produced considerable side effects. 
Consequently only a few products were found fit for 
clinical use and of these the best one turned out to be 
3(4-methyl-1-piperazinyl-iminomethyl)rifamycin SV 
(rifampicin). This compound is successfully employed 
in the oral treatment of tuberculosis and a number of 
diseases caused by Gram-positive bacteria. According 
to preliminary data it is also effective against trachoma 
and leprosy. 
Studies of the mode of action of rifamycins showed 
them to inhibit the DNA-dependent bacterial RNA 
polymerase, forming stable complexes with it. Rifa- 
mycin attacks the /?-subunits of this enzyme. These 
antibiotics do not affect the RNA polymerase of marn- 
malia, which explains their low toxicity. 
E.Ya.Gren (Riga, USSR) reported on the prepara- 
tion of a number of new products of the transfomra- 
tion of rifamycin B. 
Recently research has been attracted more and 
more to those antibiotics whose action is associated 
with increases in the permeability of biological mem- 
branes to alkali metal ions. The best known members 
of this class are the macrocyclic depsipeptides (valino- 
mycin, enniatins) the chemistry of which had been 
studied mainly in the laboratory of the late M.M. 
Shemyakin (Moscow), whose death occurred suddenly 
while he was honorary president of the Symposium. 
Shemyakin’s paper at the present Pre-symposium was 
devoted to structure-function relations of valinomycin 
and allied cyclodepsipeptides. Investigation of the 
physicochemical properties of valinomycin and its 
synthetic analogs in solution and correlation of these 
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properties with the metal binding capacity of these 
compounds made it possible to establish the rigidity 
limits of the so-called “bracelet” conformation charac- 
teristic of valinomycin and to outline ways for the 
synthesis of compounds with altered ionic selectivity. 
The study of the complexing properties of the cyclo- 
depsipeptides and cyclopeptides has become of special 
interest because the ion-dipole type of cation binding 
by a spatially ordered system of ligand groups (amide 
and/or ester carbonyls) is apparently also characteristic 
of the selective cation binding sites of proteins (e.g. 
transport ATPases). 
Shemyakin devoted much of his report to the 
mode of action of the cyclodepsipeptides. Many of 
the valinomycin analogs which bind K+ ions in solu- 
tion and which increase the K+ permeability of model 
phospholipid membranes are devoid of antibiotic 
activity. This had been earlier ascribed to the specific 
structure of bacterial membranes, limiting the possible 
structural variations of the active cyclodepsipeptide. 
Similar proposals had also been made with respect to 
the membranes of valinomycin resistant microorgan- 
isms. However, it turned out that antibiotically in- 
active compounds increase the K! permeability of the 
microbial cell (Streptococcus faecalis, Staphylococcus 
aureus), their effect with respect to valinomycin being 
about the same as that for model membranes. If the 
cyclodepsipeptide-induced shifts of the ionic composi- 
tion of the cells are increased by changing the salt 
composition of the medium, sensitivity to valinomycin 
and its “inactive” analogs can be observed among 
formerly “resistant” microorganisms. In the case of the 
S. aureus 209-P such an effect was achieved by increas- 
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ing the K+ ion concentration in the medium from 10 
mM to 100 mM. The above experiments were reported 
in detail by A.M.Shkrob (Moscow, USSR). 
J.Boothe (Pearl River, USA) discussed in detail the 
structure-activity relations of the important tetra- 
cycline group. He made a number of generalizations 
about chemical transformations of naturally oc- 
curring antibiotics, work undertaken to improve the 
properties of the parent compounds. Of greatest inter- 
est was 2-dimethylamino-6-deoxy-&demethyltetra- 
cycline (minocycline) whose potency excelled that of 
the other tetracyclines. Particularly interesting is its 
ability to inhibit the growth of strains resistant to the 
other membranes of this group. Moreover, resistance 
to it develops much more slowly than to the other 
tetracyclines. 
M.N.Kolosov (Moscow, USSR) described chemical 
studies of the aureolic acid group of antibiotics. The 
author led a programme of research that established the 
structures of the antitumor antibiotic aureolic acid 
(mithramycin) and the allied substances olivomycins, 
chromomycins and aburamycins. All these compounds 
are polyhydroxy hydroanthracenic glycosides, whose 
aglycones are olivin or its methyl homolog chromo- 
mycinone and which contain two carbohydrate chains 
in the 2 and 6 positions. The most active members of 
this group (aureolic acid, olivomycins A and B and 
chromomycins AZ and A3) have, in position 2, a side 
chain of 3 carbohydrate residues ending with a 
branched sugar mycarose or acylolivomycose. The 
corresponding tetrosides lacking this sugar (olivomycin 
D, chromomycin 4) are much less biologically active 
and may be regarded as unfinished antibiotics. Of all 
these substances olivomycin A has the best therapeutic 
index. Besides aureolic acid, an accompanying biologi- 
cally inactive metabolite, chromocyclomycin, was 
isolated and its structure elucidated. Its aglycone, 
chromocycline, is biogenetically close to chromomyci- 
none on the one hand, and to the tetracycline anti- 
biotics on the other (scheme 2). 
G.B.Lokshin (Moscow, USSR) reported the struc- 
ture of a new member of the above group of substances, 
antibiotic 6604-9A. 
Although polyene macrolides are among the most 
Aureolic acid 
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important of the antibiotics their chemical study pro- 
ceeded very slowly for a long time. Only in recent, 
years has a much more lively progress in this field 
been noted, yielding the structures of rimocidm, pi- 
maricin, lucensomycin, the tetrins A and B, hexamycin 
and other compounds. Generalizations about studies 
in this field were the subject matter of the papers by 
E.Borowski (Gdansk, Poland) and H.Thrum and 
R.Schlegel (Jena, GDR). 
Borowski noted that improved methods of separat- 
ing polyenes have made it possible to isolate new sub- 
stances from previously described preparations, for 
instance, the isolation of perimycins A, B and C from 
perimycin. The author presented a refined classification 
of heptaene antibiotics dividing them into 4 sub-groups 
depending upon the nitrogen-containing components: 
(1) non-aromatic compounds containing the amino 
sugar mycosamine (candidin, candidinin, candioin, 
amphotericin B, mycoheptyne); (2) aromatic compounds 
containing mycosamine and p-aminoacetophenone 
(candicidines, trichomycins, levorins, hamycin etc.); 
(3) aromatic compounds containing mycosamine and 
p-N-methylaminoacetophenone (aureofungin, heda- 
mycin); (4) aromatic compounds containing the amino 
sugar perosamine and p-N-methylaminoacetophenone 
(perimycins A and C). Using the accumulated data, 
the author developed a general scheme for elucidating 
the structures of polyene antibiotics such as was used 
in establishing the structure of candidin and amphoteri- 
tin B and in correcting the formula of nystatin. 
The author also dwelt on some of the biological 
properties of polyene antibiotics, in particular their 
ability to form complexes with cholesterol, making it 
possible to vary the cholesterol content in the organism 
(experiments on dogs). 
H.Thrum and R.Schlegel described their studies of 
the peculiar group, the mycoticin-flavomycin poly- 
enes, the distinctive feature of which is the conjugation 
of a pentaene grouping with a carbonyl. There are at 
least three different antibiotics in this group: mycoti- 
tin A (flavofungin “a”), mycoticin B (flavofungin “b”) 
and flavomycoin. They differ in optical rotation, mole- 
cular weights and other properties. The structures of 
the first two have already been reported and for flavo- 
mycoin (C41&a01u) the authors propose the following 
partial formula: 
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Dermostatin also belongs to this type of compounds, 
although it has a hexaene grouping. 
L.A.Vetlugina (Alma-Ata, USSR) reported on the 
antibiotic roseofungin which differs in properties from 
all other substances of the flavomycoin-mycoticin- 
flavofungin group. 
A.S.Khokhlov (Moscow, USSR) described the 
studies of the streptothricins carried out in the last 
years under his guidance. It was found that six in- 
dividual substances (streptothricins A-F) can be isolated 
from partially purified streptothricins. Their structures 
are formulated below, they differ in the number of 
/3-lysine residues they contain. A seventh antibiotic of 
this type (streptothricin X) is obtained by directed 
fermentation in the presence of large amounts of 
a-aminoadipic acid. 
F: n=l B: n=5 
E: n=2 A: n=6 
D: n=3 X: n=7 
C: n=4 
Streptothricin biosynthesis differs fundamentally 
from the biosynthesis of proteins and is not suppressed 
by chloramphenicol. All streptothricins are formed 
by the same route, streptothricin F is formed first and 
fl-lysine residues are added to it. The fl-lysine residues 
are formed from ol-lysine, but not by transamination. 
The streptothricins strongly suppress protein bio- 
synthesis in a Nierenberg cell-free system containing 
E. coli B ribosomes. Their activity is commensurate 
4 
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with that of chloramphenicol, e.g. protein biosynthesis 
is inhibited by 98-99% by 400 PM chloramphenicol 
and by 800 @vi streptothricin B. Antibacterially in- 
active products of mild acid-inactivation of the strep- 
tothricins show an effect on protein biosynthesis 
similar to that of the parent antibiotics. 
H.Yonehara (Tokyo, Japan) in his paper on the 
development of antibiotics for agriculture use in Japan, 
discussed the results of work begun in 1952 primarily 
concerned with the search for antifungal agents for 
the treatment of rice. The antibiotics antimycin (blast- 
mycin), blasticidin S, kasugamycin and the polyoxins 
proved effective and the last three have found practi- 
cal application. The antimycins have a strong toxic 
effect on fish and therefore cannot be used. The 
author also presented methods for isolation of blasti- 
cidins A and S and described the properties of these 
antibiotics. The possibility of chemical or microbial 
synthesis of blasticidin S from the products of its 
splitting, blastidic acid and cytosinine, is of great inter- 
est. This allows the preparation of new analogs with 
altered amino acid moieties. Study of polyoxins 
showed the presence of about 30 compounds in a 
crude preparation, Their structure and structure-acti- 
vity relationships are under investigation. 
R.Bognar (Debrecen, Hungary) devoted his lecture 
“Oligosaccharide moieties of some antibiotics” to a 
number of very important problems confronting 
modern organic chemistry. Sugars, many hitherto un- 
known, have been found as constituents of several 
dozen antibiotics. Bognar reviewed available data on 
the structures of the oligosaccharide fragments of 
streptomycin, neomycin, paromomycin, olivomycin, 
chromomycin, amycetin, everninomycin, saturated 
macrolide antibiotics, the anthracycline antibiotics and 
many others. He paid considerable attention to the 
oligosaccharide moiety of the ristomycin antibiotics 
(ristocetins) and in particular showed how the rham- 
nose and mannose residues were attached to the glu- 
cose residue in ristomycin A. N.N.Lomakina (Moscow, 
USSR) reported data on a new amino sugar from the 
ristomycins. 
E.Gross (Bethesda, USA) spoke about antibiotics 
containing as component parts o&unsaturated a-amino 
acids, substances that have lately attracted much at- 
tention. The author first listed a numer of naturally 
occurring compounds with such amino acids (albonour- 
sin, telomycin, stendomycin, etc.), but dwelt mostly 
on nisin, an antibiotic of highly diversified biological 
activity. He had found conditions for the selective 
cleavage of nisin with cyanogen bromide (under ordina- 
ry conditions such treatment led to a very complicated 
mixture of products), isolated and characterized the 
N- and C-terminal fragments and established the struc- 
ture of the N-terminal undecapeptide shown in scheme 3. 
The part played by q P-unsaturated a-amino acids 
in creating a definite structure of the antibiotic mole- 
cule necessary for its biological activity was also con- 
sidered. 
P.D.Reshetov (Moscow, USSR) presented data on 
the purification and properties of two other antibio- 
tics belonging to the nisins: subtilin and cinnamycin. 
In his lecture J.Strominger (Cambridge, USA) re- 
viewed the work aimed at elucidating the mechanism 
by which the penicillins, cephalosporins and other 
antibiotics inhibit the formation of the bacterial cell 
walls. The author regarded the wall as a gigantic three- 
dimensional molecule built up of glycan strands com- 
posed of alternating acetylglucosamine and acetyl- 
muramic acid residues, the strands being cross linked 
by peptide bridges. 
In a consideration of the biosynthesis of the poly 
glycan of cell wall, three fundamental stages can be 
distinguished. The first stage, proceeding in the cell 
cytoplasm, consists of the biosynthesis of uridine 
nucleotide precursors and leads to the formation first 
of UDP-acetyl glucosamine and UDP-acetylmuramyl 
tripeptide (containing L-alanine, D-glutamic acid and 
L-lysine) and then, by addition of D-alanyl-D-alanine, 
of the corresponding UDP-acetylmuramyl-pentapep- 
tide. Important, in the last step, are the two enzymes, 
alanine racemase and D-alanyl-D-alanine synthetase. 
Both enzymes are inhibited by D-cycloserine thus 
explaining its antibiotic action. 
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The second stage proceeds in the cell membrane. 
Here a number of processes occur. First there is formed 
a disaccharide of the pentapeptide attached to the 
lipid through a pyrophosphate bridge. This is followed 
by the addition of several amino acids and finally the 
resultant molecule is built into the growing cell wall 
with simultaneous formation of a C,, alcohol pyro- 
phosphate. 
CH3 CH3 
I 
Ristomycin and vancomycin interfere with transfer 
of the molecule formed to the bacterial wall while 
bacitracin inhibits the dephosphorylation of the Css 
alcohol pyrophosphate and interrupts the return of 
the lipid carrier into the cycle. 
The final stage consists of the formation of cross 
links between two peptidoglycan strands by transpep 
tidation and simultaneous cleavage of the terminal 
D-alanine. This stage occurs on the external surface of 
the membrane. It is here that the penicillins and ce- 
phalosporins exert their inhibiting action, reacting 
with two enzymes catalyzing the above reactions, 
namely peptidoglycan transpeptidase and D-alanine 
carboxypeptidase. The first enzyme is inactivated ir- 
reversibly, the second, reversibly, its activity being 
restored by treatment, for instance, with hydroxyl- 
amine or ethylmercaptane. 
In a discussion of this paper G.Peck (Moscow, USSR) 
noted that in this excellent work where it was possible 
to pinpoint the site of action of the penicillins on bac- 
teria, the part played by the side chain of these com- 
pounds is worthy of attention. N.M.R. and other physi- 
cohemical studies seemed to show that the side chain 
does not affect the bicyclic penicillin ring system in the 
ground state, although it is known to have a profound 
effect on the stability of these compounds. The side 
chain must therefore apparently play a definite role in 
the activated complex and should be taken into con- 
sideration in mechanistic treatment of the splitting of 
the @-lactam ring although of course the enzymatic re- 
actions may proceed differently. 
B.Weisblum (Madison, USA) reported on his dis- 
covery of the ability of erythromycin to modify 
Staphylococcus aureus ribosomes, as a result of which 
he was able to obtain strains resistant to three different 
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types of the SOS ribosome subunits (macrolides, lincos- 
aminides and antibiotics of the type of streptogramine 
B). The resistant cultures again become antibiotic- 
susceptible when cultivated for 90 min in the absence 
of erythromycin. The induction of resistance is sup- 
pressed by chloramphenicol (inhibitor of protein bio- 
synthesis) and by streptovaricin (inhibitor of the RNA 
formation) but not by novobiocin (inhibitor of DNA 
biosynthesis). Further study revealed two types of 
induced resistance. Ribosomes isolated from both 
types of resistant cells were changed in their functional 
properties and also probably in their structure. 
F.Hahn (Washington, USA), W.Kersten (Erlangen, 
GFR) and H.Kersten (Erlangen, GFR) devoted their 
lectures to various aspects of the interaction between 
antibiotics and nucleic acids. The first two authors 
studied the reactions in vitro, whereas the last author 
was concerned with the properties of nucleic acids 
after the action of antibiotics on the microbial cell. 
F.Hahn showed that antibiotics and other drugs 
forming complexes with DNA can be divided into two 
classes according to the binding mechanism. Members 
of one group such as spermine, distamycin etc. com- 
plex with groups on the periphery of the double helix, 
whereas with most antibiotics and other pharmaceuti- 
cal preparations (for example, atebrin, chloroquine, 
quinine) complexing is accompanied by intercalation. 
In both cases increases in rigidity of the double 
helix occurs hindering its unfolding. The binding by 
DNA of chloroquine, atebrin and quinine inhibits the 
polymerization reactions not only of DNA, but also 
of RNA. 
W.Kersten showed that in the formation of com- 
plexes with DNA the chromophore grouping of the 
anthracycline antibiotics undergoes conformational 
changes. Daunomycin and nogalamycin differ from 
the chromomycins and mithramycin in the mode of 
their interaction with DNA. The two latter compounds 
preferentially bind GC pairs whereas the former two 
react also with AT pairs. 
Granaticin inhibits RNA synthesis which may be 
ascribed to binding of the sulphydryl groups of pro- 
teins controlling the synthesis of RNA. 
H.Kersten dwelt on the significance of methyl 
groups for the functioning of RNA. Pactamycin, an 
antibiotic inhibiting protein synthesis, stimulates the 
formation of RNA. Pactamycin- (and also tetracycline-) 
treated ribosomal and messenger RNA from B. subtilis 
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contain relatively fewer methyl groups than do those the functional role of methyl groups in the synthesis 
from normal cells. of RNA and of proteins. 
In a cell free model with polyU as mRNA, 70 S 
ribosomes from pactamycin treated cells were found 
to be less active in the synthesis of polyphenylalanine. 
The acceptor activity of tRNA from the pactamycin- 
treated cells is reduced towards phenylalanine, but 
not towards lysine, valine or alanine. All these data 
are of considerable interest from the point of view of 
Closing the Pre-symposium D.Gottlieb (Urbana, 
USA) stressed the importance of studying the inter- 
action of antibiotics with the living cell for comprehend- 
ing the principles of its structure and functioning. He 
noted the timeliness and good organization of this 
meeting. 
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